2025-08-25 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
17,791,486 |
15,726,349 |
|
|
|
2025-08-19 |
13G
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
|
2,366,995 |
|
|
|
2025-08-14 |
13G/A
|
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
|
|
3,579,209 |
3,480,144 |
|
|
|
2025-08-14 |
13G/A
|
ZURA / Zura Bio Limited
|
|
6,216,327 |
4,616,514 |
|
|
|
2025-08-14 |
13G/A
|
TERN / Terns Pharmaceuticals, Inc.
|
|
5,576,558 |
7,495,000 |
|
|
|
2025-08-14 |
13G/A
|
PLRX / Pliant Therapeutics, Inc.
|
|
5,750,000 |
3,947,807 |
|
|
|
2025-08-14 |
13G/A
|
RGLS / Regulus Therapeutics Inc.
|
|
6,888,424 |
0 |
|
|
|
2025-08-14 |
13G/A
|
MBX / MBX Biosciences, Inc.
|
|
3,018,935 |
2,188,592 |
|
|
|
2025-08-14 |
13G/A
|
MAZE / Maze Therapeutics, Inc.
|
|
3,023,484 |
3,948,910 |
|
|
|
2025-08-14 |
13G/A
|
KRRO / Korro Bio, Inc.
|
|
850,000 |
277,966 |
|
|
|
2025-08-14 |
13G/A
|
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
12,300,000 |
15,401,751 |
|
|
|
2025-08-14 |
13G/A
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
2,821,171 |
1,203,244 |
|
|
|
2025-08-14 |
13G/A
|
GERN / Geron Corporation
|
|
35,000,000 |
43,000,000 |
|
|
|
2025-08-14 |
13G/A
|
ALLK / Allakos Inc.
|
|
7,232,701 |
0 |
|
|
|
2025-08-04 |
13G
|
IMA / ImageneBio, Inc.
|
|
|
878,516 |
|
|
|
2025-08-04 |
13G/A
|
IKNA / Ikena Oncology, Inc.
|
|
2,515,513 |
0 |
|
|
|
2025-07-28 |
13G
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
2,352,960 |
|
|
|
2025-06-20 |
13G
|
JBIO / Jade Biosciences, Inc.
|
|
|
2,784,648 |
|
|
|
2025-05-16 |
13G
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
6,000,000 |
7,000,000 |
|
|
|
2025-05-15 |
13G/A
|
TERN / Terns Pharmaceuticals, Inc.
|
|
6,100,000 |
5,576,558 |
|
|
|
2025-05-15 |
13G/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
4,000,000 |
3,442,833 |
|
|
|
2025-05-15 |
13G/A
|
NRIX / Nurix Therapeutics, Inc.
|
|
4,125,000 |
5,500,000 |
|
|
|
2025-05-15 |
13G/A
|
OCUL / Ocular Therapeutix, Inc.
|
|
9,230,769 |
15,458,138 |
|
|
|
2025-05-15 |
13G/A
|
MNMD / Mind Medicine (MindMed) Inc.
|
|
6,666,667 |
6,500,000 |
|
|
|
2025-05-15 |
13G/A
|
IVVD / Invivyd, Inc.
|
|
10,953,937 |
9,722,254 |
|
|
|
2025-05-15 |
13G/A
|
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
9,000,000 |
12,300,000 |
|
|
|
2025-05-15 |
13G/A
|
GH / Guardant Health, Inc.
|
|
6,000,560 |
5,443,721 |
|
|
|
2025-05-15 |
13G/A
|
ETNB / 89bio, Inc.
|
|
6,477,949 |
13,816,333 |
|
|
|
2025-05-15 |
13G/A
|
CNTX / Context Therapeutics Inc.
|
|
7,419,355 |
7,419,355 |
|
|
|
2025-05-15 |
13G/A
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
3,330,236 |
2,821,171 |
|
|
|
2025-05-15 |
13G/A
|
ALLK / Allakos Inc.
|
|
2,510,736 |
7,232,701 |
|
|
|
2025-05-13 |
13G
|
ORKA / Oruka Therapeutics, Inc.
|
|
|
1,896,780 |
|
|
|
2025-04-10 |
13G
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
3,250,000 |
|
|
|
2025-03-26 |
13G
|
IMVT / Immunovant, Inc.
|
|
1,000,000 |
9,500,000 |
|
|
|
2025-03-25 |
13G
|
GERN / Geron Corporation
|
|
7,575,049 |
35,000,000 |
|
|
|
2025-03-24 |
13G
|
DNTH / Dianthus Therapeutics, Inc.
|
|
|
2,357,702 |
|
|
|
2025-02-14 |
13G
|
NRIX / Nurix Therapeutics, Inc.
|
|
2,997,830 |
4,125,000 |
|
|
|
2025-02-14 |
13G
|
IKNA / Ikena Oncology, Inc.
|
|
|
2,515,513 |
|
|
|
2025-02-14 |
13G/A
|
OKUR / OnKure Therapeutics, Inc.
|
|
660,136 |
523,989 |
|
|
|
2025-02-14 |
13G/A
|
PYXS / Pyxis Oncology, Inc.
|
|
4,184,100 |
0 |
|
|
|
2025-02-14 |
13G/A
|
ENGN / enGene Holdings Inc.
|
|
2,250,000 |
4,557,575 |
|
|
|
2025-02-14 |
13G/A
|
EDIT / Editas Medicine, Inc.
|
|
5,473,086 |
0 |
|
|
|
2025-02-14 |
13G/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
4,063,676 |
3,460,756 |
|
|
|
2025-02-14 |
13G/A
|
NKTR / Nektar Therapeutics
|
|
15,922,655 |
1,975,998 |
|
|
|
2025-02-14 |
13G/A
|
NRIX / Nurix Therapeutics, Inc.
|
|
2,997,830 |
3,000,000 |
|
|
|
2025-02-14 |
13G/A
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
4,096,452 |
609,900 |
|
|
|
2025-02-14 |
13G/A
|
SYRS / Syros Pharmaceuticals, Inc.
|
|
699,281 |
|
|
|
|
2025-02-14 |
13G/A
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
3,490,506 |
3,330,236 |
|
|
|
2025-02-10 |
13G
|
TECX / Tectonic Therapeutic, Inc.
|
|
|
1,401,938 |
|
|
|
2025-02-07 |
13G
|
MAZE / Maze Therapeutics, Inc.
|
|
|
3,023,484 |
|
|
|
2025-01-17 |
13G
|
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
|
|
|
9,274,589 |
|
|
|
2025-01-13 |
13G
|
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
900,000 |
9,000,000 |
|
|
|
2024-12-23 |
13G
|
ETNB / 89bio, Inc.
|
|
2,000,000 |
6,477,949 |
|
|
|
2024-12-23 |
13G
|
RAPT / RAPT Therapeutics, Inc.
|
|
0 |
14,116,000 |
|
|
|
2024-11-22 |
13G/A
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
6,000,000 |
|
|
|
2024-11-22 |
13G
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
6,220,265 |
|
|
|
2024-11-14 |
13G/A
|
AMAM / Ambrx Biopharma Inc.
|
|
3,710,412 |
0 |
|
|
|
2024-11-14 |
13G/A
|
APGE / Apogee Therapeutics, Inc.
|
|
2,323,456 |
1,000,000 |
|
|
|
2024-11-14 |
13G/A
|
VIGL / Vigil Neuroscience, Inc.
|
|
3,649,726 |
1,553,996 |
|
|
|
2024-11-14 |
13G/A
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
32,932,392 |
25,440,200 |
|
|
|
2024-11-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
7,522,281 |
531,857 |
|
|
|
2024-11-14 |
13G/A
|
TRML / Tourmaline Bio, Inc.
|
|
1,815,854 |
0 |
|
|
|
2024-11-14 |
13G/A
|
AGLE / Aeglea BioTherapeutics Inc
|
|
2,184,440 |
1,000,000 |
|
|
|
2024-11-14 |
13G/A
|
RPTX / Repare Therapeutics Inc.
|
|
2,992,731 |
0 |
|
|
|
2024-11-14 |
13G/A
|
SLNCF / Silence Therapeutics plc
|
|
5,854,740 |
3,000,000 |
|
|
|
2024-11-14 |
13G/A
|
RLMD / Relmada Therapeutics, Inc.
|
|
2,044,507 |
674,833 |
|
|
|
2024-11-14 |
13G/A
|
RAPT / RAPT Therapeutics, Inc.
|
|
1,793,966 |
0 |
|
|
|
2024-11-14 |
13G/A
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
19,125,150 |
0 |
|
|
|
2024-11-14 |
13G/A
|
HLVX / HilleVax, Inc.
|
|
2,900,000 |
0 |
|
|
|
2024-11-14 |
13G/A
|
GERN / Geron Corporation
|
|
29,583,449 |
7,575,049 |
|
|
|
2024-11-14 |
13G/A
|
CLYM / Climb Bio, Inc.
|
|
3,904,785 |
2,169,143 |
|
|
|
2024-11-14 |
13G/A
|
DYN / Dyne Therapeutics, Inc.
|
|
2,000,000 |
3,282,000 |
|
|
|
2024-11-14 |
13G/A
|
ANAB / AnaptysBio, Inc.
|
|
2,036,990 |
0 |
|
|
|
2024-11-14 |
13G/A
|
AGEN / Agenus Inc.
|
|
31,697,539 |
0 |
|
|
|
2024-11-14 |
13G/A
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
3,040,248 |
4,000,000 |
|
|
|
2024-11-14 |
13G/A
|
NKTR / Nektar Therapeutics
|
|
18,400,000 |
15,922,655 |
|
|
|
2024-11-14 |
13G/A
|
IVVD / Invivyd, Inc.
|
|
9,000,000 |
10,953,937 |
|
|
|
2024-11-14 |
13G/A
|
KRRO / Korro Bio, Inc.
|
|
714,285 |
850,000 |
|
|
|
2024-11-14 |
13G/A
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
2,284,372 |
4,096,452 |
|
|
|
2024-11-14 |
13G/A
|
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
11,869,297 |
15,272,172 |
|
|
|
2024-11-14 |
13G/A
|
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
|
|
4,297,438 |
3,579,209 |
|
|
|
2024-10-24 |
13D/A
|
DVAX / Dynavax Technologies Corporation
|
|
12,526,486 |
17,791,486 |
|
|
|
2024-10-23 |
13G/A
|
OKUR / OnKure Therapeutics, Inc.
|
|
|
660,136 |
|
|
|
2024-10-11 |
13G
|
OKUR / OnKure Therapeutics, Inc.
|
|
|
684,156 |
|
|
|
2024-10-07 |
13G/A
|
GH / Guardant Health, Inc.
|
|
7,000,000 |
6,000,560 |
|
|
|
2024-10-07 |
13G
|
GH / Guardant Health, Inc.
|
|
7,000,000 |
6,580,257 |
|
|
|
2024-09-23 |
13G
|
MBX / MBX Biosciences, Inc.
|
|
|
3,018,935 |
|
|
|
2024-09-16 |
13D
|
DVAX / Dynavax Technologies Corporation
|
|
7,093,214 |
12,526,486 |
|
|
|
2024-07-12 |
13G
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
32,932,392 |
|
|
|
2024-07-02 |
13G
|
CLYM / Climb Bio, Inc.
|
|
|
3,904,785 |
|
|
|
2024-05-10 |
13G
|
CNTX / Context Therapeutics Inc.
|
|
|
7,419,355 |
|
|
|
2024-04-26 |
13G
|
KRRO / Korro Bio, Inc.
|
|
|
714,285 |
|
|
|
2024-04-26 |
13G
|
INO / Inovio Pharmaceuticals, Inc.
|
|
|
2,593,822 |
|
|
|
2024-04-22 |
13G/A
|
ZURA / Zura Bio Limited
|
|
4,205,000 |
6,216,327 |
|
|
|
2024-04-12 |
13G
|
GH / Guardant Health, Inc.
|
|
|
7,000,000 |
|
|
|
2024-04-05 |
13G
|
AVTX / Avalo Therapeutics, Inc.
|
|
|
114,775 |
|
|
|
2024-03-22 |
13G
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
|
3,040,248 |
|
|
|
2024-03-22 |
13G
|
CYBN / Cybin Inc.
|
|
|
58,139,535 |
|
|
|
2024-03-22 |
13G
|
RGLS / Regulus Therapeutics Inc.
|
|
|
6,888,424 |
|
|
|
2024-03-15 |
13G
|
MNMD / Mind Medicine (MindMed) Inc.
|
|
|
6,666,667 |
|
|
|
2024-03-08 |
13G
|
PYXS / Pyxis Oncology, Inc.
|
|
|
4,184,100 |
|
|
|
2024-02-23 |
13G
|
ENGN / enGene Holdings Inc.
|
|
|
2,250,000 |
|
|
|
2024-02-14 |
13G/A
|
VIGL / Vigil Neuroscience, Inc.
|
|
3,684,619 |
3,649,726 |
|
|
|
2024-02-14 |
13G/A
|
ETNB / 89bio, Inc.
|
|
4,331,499 |
2,000,000 |
|
|
|
2024-02-14 |
13G/A
|
AMAM / Ambrx Biopharma Inc.
|
|
3,710,412 |
3,710,412 |
|
|
|
2024-02-14 |
13G/A
|
ZURA / Zura Bio Limited
|
|
4,205,000 |
4,205,000 |
|
|
|
2024-02-14 |
13G/A
|
VRDN / Viridian Therapeutics, Inc.
|
|
3,312,974 |
5,378,997 |
|
|
|
2024-02-14 |
13G/A
|
VALN / Valneva SE - Depositary Receipt (Common Stock)
|
|
10,513,265 |
7,526,807 |
|
|
|
2024-02-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
4,582,000 |
7,522,281 |
|
|
|
2024-02-14 |
13G/A
|
TERN / Terns Pharmaceuticals, Inc.
|
|
3,560,000 |
6,100,000 |
|
|
|
2024-02-14 |
13G/A
|
AGLE / Aeglea BioTherapeutics Inc
|
|
7,258,056 |
2,184,440 |
|
|
|
2024-02-14 |
13G/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
3,254,132 |
4,063,676 |
|
|
|
2024-02-14 |
13G/A
|
SLNCF / Silence Therapeutics plc
|
|
5,854,740 |
5,854,740 |
|
|
|
2024-02-14 |
13G/A
|
RPTX / Repare Therapeutics Inc.
|
|
2,727,606 |
2,992,731 |
|
|
|
2024-02-14 |
13G/A
|
RLMD / Relmada Therapeutics, Inc.
|
|
2,837,818 |
2,044,507 |
|
|
|
2024-02-14 |
13G/A
|
NKTR / Nektar Therapeutics
|
|
12,302,237 |
18,400,000 |
|
|
|
2024-02-14 |
13G/A
|
PLRX / Pliant Therapeutics, Inc.
|
|
3,104,507 |
5,750,000 |
|
|
|
2024-02-14 |
13G/A
|
RAPT / RAPT Therapeutics, Inc.
|
|
1,991,403 |
1,793,966 |
|
|
|
2024-02-14 |
13G/A
|
NRIX / Nurix Therapeutics, Inc.
|
|
2,717,171 |
2,997,830 |
|
|
|
2024-02-14 |
13G/A
|
JNCE / Jounce Therapeutics Inc
|
|
4,259,653 |
0 |
|
|
|
2024-02-14 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
7,878,119 |
0 |
|
|
|
2024-02-14 |
13G/A
|
INZY / Inozyme Pharma, Inc.
|
|
3,250,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
IMVT / Immunovant, Inc.
|
|
9,710,000 |
1,000,000 |
|
|
|
2024-02-14 |
13G/A
|
IMUX / Immunic, Inc.
|
|
4,022,989 |
0 |
|
|
|
2024-02-14 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
12,232,267 |
0 |
|
|
|
2024-02-14 |
13G/A
|
HLVX / HilleVax, Inc.
|
|
2,900,000 |
2,900,000 |
|
|
|
2024-02-14 |
13G/A
|
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
7,940,346 |
900,000 |
|
|
|
2024-02-14 |
13G/A
|
GERN / Geron Corporation
|
|
24,022,883 |
29,583,449 |
|
|
|
2024-02-14 |
13G/A
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
2,656,901 |
2,284,372 |
|
|
|
2024-02-14 |
13G/A
|
EWTX / Edgewise Therapeutics, Inc.
|
|
3,374,394 |
2,537,176 |
|
|
|
2024-02-14 |
13G/A
|
ESPR / Esperion Therapeutics, Inc.
|
|
6,345,790 |
0 |
|
|
|
2024-02-14 |
13G/A
|
EDIT / Editas Medicine, Inc.
|
|
4,493,416 |
5,473,086 |
|
|
|
2024-02-14 |
13G/A
|
DYN / Dyne Therapeutics, Inc.
|
|
4,500,000 |
2,000,000 |
|
|
|
2024-02-14 |
13G/A
|
DVAX / Dynavax Technologies Corporation
|
|
6,556,180 |
7,093,214 |
|
|
|
2024-02-14 |
13G/A
|
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
15,000,000 |
11,869,297 |
|
|
|
2024-02-14 |
13G/A
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
2,819,045 |
3,490,506 |
|
|
|
2024-02-14 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
1,816,531 |
0 |
|
|
|
2024-02-14 |
13G/A
|
APGE / Apogee Therapeutics, Inc.
|
|
3,023,456 |
2,323,456 |
|
|
|
2024-02-14 |
13G/A
|
ANAB / AnaptysBio, Inc.
|
|
1,360,176 |
2,036,990 |
|
|
|
2024-02-14 |
13G/A
|
ALLK / Allakos Inc.
|
|
5,000,000 |
2,510,736 |
|
|
|
2024-02-14 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
1,704,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
AGEN / Agenus Inc.
|
|
27,000,000 |
31,697,539 |
|
|
|
2024-02-14 |
13G/A
|
ABOS / Acumen Pharmaceuticals, Inc.
|
|
3,952,000 |
0 |
|
|
|
2024-02-12 |
13G
|
IVVD / Invivyd, Inc.
|
|
|
9,000,000 |
|
|
|
2024-01-26 |
13G
|
ALLK / Allakos Inc.
|
|
4,899,179 |
5,000,000 |
|
|
|
2024-01-26 |
13G/A
|
ALLK / Allakos Inc.
|
|
4,899,179 |
2,510,736 |
|
|
|
2024-01-19 |
13G
|
DYN / Dyne Therapeutics, Inc.
|
|
2,684,200 |
4,500,000 |
|
|
|
2024-01-19 |
13G/A
|
DYN / Dyne Therapeutics, Inc.
|
|
2,684,200 |
2,000,000 |
|
|
|
2023-12-22 |
13G
|
OCUL / Ocular Therapeutix, Inc.
|
|
|
9,230,769 |
|
|
|
2023-11-02 |
13G
|
AMAM / Ambrx Biopharma Inc.
|
|
|
3,710,412 |
|
|
|
2023-11-02 |
13G
|
ALGS / Aligos Therapeutics, Inc.
|
|
|
7,295,967 |
|
|
|
2023-10-30 |
13G
|
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
|
|
|
4,297,438 |
|
|
|
2023-10-27 |
13G
|
TRML / Tourmaline Bio, Inc.
|
|
|
1,815,854 |
|
|
|
2023-10-23 |
13G
|
RAPT / RAPT Therapeutics, Inc.
|
|
|
1,991,403 |
|
|
|
2023-10-02 |
13G
|
ANAB / AnaptysBio, Inc.
|
|
|
1,360,176 |
|
|
|
2023-09-29 |
13G
|
HLVX / HilleVax, Inc.
|
|
|
2,900,000 |
|
|
|
2023-08-04 |
13G
|
EDIT / Editas Medicine, Inc.
|
|
|
4,493,416 |
|
|
|
2023-07-28 |
13G
|
TERN / Terns Pharmaceuticals, Inc.
|
|
|
3,560,000 |
|
|
|
2023-07-24 |
13G
|
APGE / Apogee Therapeutics, Inc.
|
|
|
3,023,456 |
|
|
|
2023-06-30 |
13G
|
AGLE / Aeglea BioTherapeutics Inc
|
|
|
7,258,056 |
|
|
|
2023-06-15 |
13G
|
ZURA / Zura Bio Limited
|
|
|
4,205,000 |
|
|
|
2023-05-19 |
13G
|
DVAX / Dynavax Technologies Corporation
|
|
|
6,556,180 |
|
|
|
2023-04-14 |
13G
|
NKTR / Nektar Therapeutics
|
|
|
12,302,237 |
|
|
|
2023-04-14 |
13G
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
|
3,254,132 |
|
|
|
2023-03-20 |
13G
|
PLRX / Pliant Therapeutics, Inc.
|
|
|
3,104,507 |
|
|
|
2023-03-20 |
13G
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
19,125,150 |
|
|
|
2023-02-24 |
13G
|
NRIX / Nurix Therapeutics, Inc.
|
|
2,266,569 |
2,717,171 |
|
|
|
2023-02-14 |
13G/A
|
KROS / Keros Therapeutics, Inc.
|
|
1,300,000 |
0 |
|
|
|
2023-02-14 |
13G/A
|
VRDN / Viridian Therapeutics, Inc.
|
|
1,819,689 |
3,312,974 |
|
|
|
2023-02-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
3,435,200 |
4,582,000 |
|
|
|
2023-02-14 |
13G/A
|
RPTX / Repare Therapeutics Inc.
|
|
2,100,000 |
2,727,606 |
|
|
|
2023-02-14 |
13G/A
|
TCDA / Tricida Inc
|
|
5,857,829 |
4,666,666 |
|
|
|
2023-02-14 |
13G/A
|
RLMD / Relmada Therapeutics, Inc.
|
|
2,481,000 |
2,837,818 |
|
|
|
2023-02-14 |
13G/A
|
PASG / Passage Bio, Inc.
|
|
3,216,997 |
0 |
|
|
|
2023-02-14 |
13G/A
|
NRIX / Nurix Therapeutics, Inc.
|
|
2,436,164 |
2,266,569 |
|
|
|
2023-02-14 |
13G/A
|
NUVB / Nuvation Bio Inc.
|
|
11,471,281 |
8,221,188 |
|
|
|
2023-02-14 |
13G/A
|
NKTX / Nkarta, Inc.
|
|
1,965,684 |
1,354,200 |
|
|
|
2023-02-14 |
13G/A
|
MGTA / Magenta Therapeutics Inc
|
|
4,870,000 |
3,000,000 |
|
|
|
2023-02-14 |
13G/A
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
917,825 |
0 |
|
|
|
2023-02-14 |
13G/A
|
KURA / Kura Oncology, Inc.
|
|
3,362,000 |
0 |
|
|
|
2023-02-14 |
13G/A
|
KDNY / Chinook Therapeutics Inc
|
|
2,752,070 |
3,000,000 |
|
|
|
2023-02-14 |
13G/A
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
1,500,000 |
0 |
|
|
|
2023-02-14 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
9,000,000 |
7,878,119 |
|
|
|
2023-02-14 |
13G/A
|
JNCE / Jounce Therapeutics Inc
|
|
4,000,000 |
4,259,653 |
|
|
|
2023-02-14 |
13G/A
|
INZY / Inozyme Pharma, Inc.
|
|
3,250,000 |
3,250,000 |
|
|
|
2023-02-14 |
13G/A
|
IMUX / Immunic, Inc.
|
|
4,022,989 |
4,022,989 |
|
|
|
2023-02-14 |
13G/A
|
IMVT / Immunovant, Inc.
|
|
6,780,827 |
9,710,000 |
|
|
|
2023-02-14 |
13G/A
|
GBT / Global Blood Therapeutics Inc.
|
|
3,646,690 |
0 |
|
|
|
2023-02-14 |
13G/A
|
HOOK / HOOKIPA Pharma Inc.
|
|
5,035,998 |
1,240,369 |
|
|
|
2023-02-14 |
13G/A
|
FMTX / Forma Therapeutics Holdings Inc
|
|
2,686,655 |
0 |
|
|
|
2023-02-14 |
13G/A
|
DYN / Dyne Therapeutics, Inc.
|
|
2,816,950 |
2,684,200 |
|
|
|
2023-02-14 |
13G/A
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
1,900,000 |
2,656,901 |
|
|
|
2023-02-14 |
13G/A
|
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
15,000,000 |
15,000,000 |
|
|
|
2023-02-14 |
13G/A
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
1,496,138 |
2,819,045 |
|
|
|
2023-02-14 |
13G/A
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
7,841,570 |
324,238 |
|
|
|
2023-02-14 |
13G/A
|
ATXS / Astria Therapeutics, Inc.
|
|
1,816,531 |
1,816,531 |
|
|
|
2023-02-14 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
3,000,000 |
1,833,437 |
|
|
|
2023-02-14 |
13G/A
|
ALLK / Allakos Inc.
|
|
4,518,575 |
4,899,179 |
|
|
|
2023-02-14 |
13G/A
|
ARDX / Ardelyx, Inc.
|
|
14,252,831 |
0 |
|
|
|
2023-02-14 |
13G/A
|
AGEN / Agenus Inc.
|
|
15,229,187 |
27,000,000 |
|
|
|
2023-02-14 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
1,124,421 |
1,704,000 |
|
|
|
2023-02-14 |
13G/A
|
ABOS / Acumen Pharmaceuticals, Inc.
|
|
2,414,917 |
3,952,000 |
|
|
|
2023-02-03 |
13G
|
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
|
7,940,346 |
|
|
|
2023-01-13 |
13G
|
GERN / Geron Corporation
|
|
|
24,022,883 |
|
|
|
2022-12-22 |
13G
|
ATXS / Astria Therapeutics, Inc.
|
|
|
1,816,531 |
|
|
|
2022-12-19 |
13G
|
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
15,000,000 |
|
|
|
2022-10-28 |
13G
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
7,841,570 |
|
|
|
2022-10-21 |
13G
|
RLMD / Relmada Therapeutics, Inc.
|
|
|
2,481,000 |
|
|
|
2022-10-20 |
13G
|
IMUX / Immunic, Inc.
|
|
|
4,022,989 |
|
|
|
2022-10-07 |
13G
|
VALN / Valneva SE - Depositary Receipt (Common Stock)
|
|
|
10,513,265 |
|
|
|
2022-10-03 |
13G
|
ALBO / Albireo Pharma Inc
|
|
|
1,124,421 |
|
|
|
2022-09-30 |
13G
|
ALLK / Allakos Inc.
|
|
|
4,518,575 |
|
|
|
2022-09-23 |
13G
|
EWTX / Edgewise Therapeutics, Inc.
|
|
|
3,374,394 |
|
|
|
2022-09-19 |
13G
|
SYRS / Syros Pharmaceuticals, Inc.
|
|
|
699,281 |
|
|
|
2022-09-16 |
13G
|
ISEE / IVERIC bio Inc
|
|
|
9,000,000 |
|
|
|
2022-09-12 |
13G
|
ARDX / Ardelyx, Inc.
|
|
|
14,252,831 |
|
|
|
2022-08-22 |
13G
|
VIGL / Vigil Neuroscience, Inc.
|
|
|
3,684,619 |
|
|
|
2022-08-22 |
13G
|
SLNCF / Silence Therapeutics plc
|
|
|
5,854,740 |
|
|
|
2022-08-19 |
13G
|
HRTX / Heron Therapeutics, Inc.
|
|
|
12,232,267 |
|
|
|
2022-07-06 |
13G
|
ETNB / 89bio, Inc.
|
|
|
4,331,499 |
|
|
|
2022-06-23 |
13G
|
NUVB / Nuvation Bio Inc.
|
|
|
11,471,281 |
|
|
|
2022-06-17 |
13G
|
GBT / Global Blood Therapeutics Inc.
|
|
|
3,646,690 |
|
|
|
2022-06-10 |
13G
|
NRIX / Nurix Therapeutics, Inc.
|
|
|
2,436,164 |
|
|
|
2022-06-03 |
13G
|
FMTX / Forma Therapeutics Holdings Inc
|
|
|
2,686,655 |
|
|
|
2022-05-19 |
13G
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
917,825 |
|
|
|
2022-05-16 |
13G
|
TVTX / Travere Therapeutics, Inc.
|
|
2,450,000 |
3,435,200 |
|
|
|
2022-04-18 |
13G
|
INZY / Inozyme Pharma, Inc.
|
|
|
3,250,000 |
|
|
|
2022-04-08 |
13G
|
AGEN / Agenus Inc.
|
|
|
15,229,187 |
|
|
|
2022-03-04 |
13G
|
HOOK / HOOKIPA Pharma Inc.
|
|
|
5,035,998 |
|
|
|
2022-02-18 |
13G
|
NKTX / Nkarta, Inc.
|
|
|
1,965,684 |
|
|
|
2022-02-16 |
13G
|
KDNY / Chinook Therapeutics Inc
|
|
|
2,752,070 |
|
|
|
2022-02-14 |
13G/A
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
1,898,666 |
1,900,000 |
|
|
|
2022-02-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
3,090,200 |
2,450,000 |
|
|
|
2022-02-14 |
13G/A
|
RPTX / Repare Therapeutics Inc.
|
|
2,104,600 |
2,100,000 |
|
|
|
2022-02-14 |
13G/A
|
AVRO / AVROBIO, Inc.
|
|
2,211,129 |
1,050,132 |
|
|
|
2022-02-14 |
13G/A
|
MGTA / Magenta Therapeutics Inc
|
|
4,155,555 |
4,870,000 |
|
|
|
2022-02-14 |
13G/A
|
PASG / Passage Bio, Inc.
|
|
2,852,940 |
3,216,997 |
|
|
|
2022-02-14 |
13G/A
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
1,266,884 |
1,500,000 |
|
|
|
2022-02-14 |
13G/A
|
KROS / Keros Therapeutics, Inc.
|
|
1,288,724 |
1,300,000 |
|
|
|
2022-02-14 |
13G/A
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
1,800,000 |
1,900,000 |
|
|
|
2022-02-14 |
13G/A
|
JNCE / Jounce Therapeutics Inc
|
|
3,856,463 |
4,000,000 |
|
|
|
2022-02-14 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
2,393,876 |
3,000,000 |
|
|
|
2022-02-11 |
13G
|
IMVT / Immunovant, Inc.
|
|
|
6,780,827 |
|
|
|
2022-02-04 |
13G
|
KURA / Kura Oncology, Inc.
|
|
|
3,362,000 |
|
|
|
2022-01-27 |
13G
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
1,496,138 |
|
|
|
2022-01-27 |
13G
|
ABOS / Acumen Pharmaceuticals, Inc.
|
|
|
2,414,917 |
|
|
|
2022-01-20 |
13G
|
DYNE / Dyntek Inc
|
|
|
2,816,950 |
|
|
|
2021-12-30 |
13G
|
KROS / Keros Therapeutics, Inc.
|
|
|
1,288,724 |
|
|
|
2021-12-09 |
13G
|
ESPR / Esperion Therapeutics, Inc.
|
|
|
6,345,790 |
|
|
|
2021-11-17 |
13G
|
TCDA / Tricida Inc
|
|
|
5,857,829 |
|
|
|
2021-11-04 |
13G
|
FDMT / 4D Molecular Therapeutics, Inc.
|
|
|
1,800,000 |
|
|
|
2021-10-29 |
13G
|
RPTX / Repare Therapeutics Inc.
|
|
|
2,104,600 |
|
|
|
2021-10-25 |
13G
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
|
1,266,884 |
|
|
|
2021-10-25 |
13G
|
PASG / Passage Bio, Inc.
|
|
|
2,852,940 |
|
|
|
2021-10-12 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
|
2,393,876 |
|
|
|
2021-09-24 |
13G
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
1,819,689 |
|
|
|
2021-09-01 |
13G
|
JNCE / Jounce Therapeutics Inc
|
|
|
3,856,463 |
|
|
|
2021-08-13 |
13G
|
TVTX / Travere Therapeutics, Inc.
|
|
|
3,090,200 |
|
|
|
2021-08-05 |
13G
|
AVRO / AVROBIO, Inc.
|
|
|
2,211,129 |
|
|
|
2021-05-14 |
13G
|
MGTA / Magenta Therapeutics Inc
|
|
|
4,155,555 |
|
|
|
2021-04-22 |
13G
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
1,898,666 |
|
|
|